logo-loader
LSE:RENE FRA:RQE1

ReNeuron Group PLC

Market:
LSE
Market Cap:
£31.2 m
Price
98.00 GBX
Change
3.16%
52 weeks high
342.00
52 weeks low
57.50

In brief

ReNeuron is a leading, clinical-stage stem cell business.  Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.